Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies

Background: To fully exploit organic cation transporters for targeted drug delivery in the lung, the use of a readily available and well-characterized tissue culture model and cheap easily detectable substrates is indispensable. Objectives: To investigate the suitability of Calu-3 as tissue model for characterizing organic cation permeation across the bronchial cells using a fluorescent dye, 4-(4-(Dimethylamino)styryl)-N-methylpyridinium iodide (4-DI-1-ASP). Methods: Substrate uptake, inhibition, and transport were performed to establish active transport mechanism. Organic cation transporter expression was determined with quantitative polymerase chain reaction (qPCR), immune-histochemistry, and fluorescent microscopy. Results: 4-Di-1-ASP uptake in Calu-3 cells was concentration (Km = 2.7 ± 0.3 mM, Vmax = 4.6 ± 2.6 nmol/µg protein/30 min), temperature (uptake at 37°C>>4°C), and pH dependent (higher uptake at pH ≥ 7). L-carnitine, verapamil, and corticosterone significantly inhibited its uptake with IC50 of 28.2, 0.81, and 0.12 mM, respectively. Transport of the dye across the cells was polarized (AP→BL transport was 2.5-fold > BL→AP), saturable (Km = 43.9 ± 3.2) (µM; Vmax =0.0228± nmol/cm2/sec) and reduced 3-fold by metabolic inhibition. The expression pattern of the organic cation transporters (OCT) and carnitine/organic cation transporter (OCTN) isoforms was: OCT1<<OCT3 <OCTN1<OCTN2; OCT2 was not detected. Conclusions: Based on qPCR, immunohistochemistry, uptake and transport data, the Calu-3 cells can be used as a model for not only studying strategies for optimizing the effect of inhaled organic cations, but also for cross-validating newly-developed respiratory cell lines.

[1]  C. Ehrhardt,et al.  Organic cation transporters in the blood-air barrier: expression and implications for pulmonary drug delivery. , 2012, Therapeutic delivery.

[2]  C. Ehrhardt,et al.  Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  D. Pritchard,et al.  Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro. , 2012, International journal of pharmaceutics.

[4]  P. Högger,et al.  Methacholine delays pulmonary absorption of inhaled β(2)-agonists due to competition for organic cation/carnitine transporters. , 2012, Pulmonary pharmacology & therapeutics.

[5]  M. Garnett,et al.  Barrier characteristics of epithelial cultures modelling the airway and intestinal mucosa: a comparison. , 2011, Biochemical and biophysical research communications.

[6]  Stephan Reichl,et al.  In vitro cell culture models to study the corneal drug absorption , 2011, Expert opinion on drug metabolism & toxicology.

[7]  L. Turco,et al.  Caco‐2 Cells as a Model for Intestinal Absorption , 2011, Current protocols in toxicology.

[8]  John W Haycock,et al.  3D cell culture: a review of current approaches and techniques. , 2011, Methods in molecular biology.

[9]  T. Shaffer,et al.  Cultured Human Airway Epithelial Cells (Calu-3): A Model of Human Respiratory Function, Structure, and Inflammatory Responses , 2010, Critical care research and practice.

[10]  C. Bosquillon,et al.  Drug transporters in the lung--do they play a role in the biopharmaceutics of inhaled drugs? , 2010, Journal of pharmaceutical sciences.

[11]  T. Nakanishi,et al.  Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption. , 2010, Molecular pharmaceutics.

[12]  A. Mitra,et al.  Identification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3). , 2010, International journal of pharmaceutics.

[13]  R. Vanbever,et al.  Preclinical models for pulmonary drug delivery , 2009, Expert opinion on drug delivery.

[14]  S. Golz,et al.  The Carnitine Transporter SLC22A5 Is Not a General Drug Transporter, but It Efficiently Translocates Mildronate , 2009, Drug Metabolism and Disposition.

[15]  W. Kummer,et al.  The epithelial cholinergic system of the airways , 2008, Histochemistry and Cell Biology.

[16]  C. Ehrhardt,et al.  In vitro cell culture models for the assessment of pulmonary drug disposition. , 2008, Expert opinion on drug metabolism & toxicology.

[17]  A. Wanner,et al.  The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells. , 2007, The Journal of allergy and clinical immunology.

[18]  S. Golz,et al.  Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations. , 2007, Biochemical pharmacology.

[19]  H. Koepsell,et al.  Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications , 2007, Pharmaceutical Research.

[20]  A. Wanner,et al.  Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway. , 2007, American journal of respiratory cell and molecular biology.

[21]  M. Inazu,et al.  Molecular and functional characterization of an Na+‐independent choline transporter in rat astrocytes , 2005, Journal of neurochemistry.

[22]  C. Lehr,et al.  Cell culture models of the respiratory tract relevant to pulmonary drug delivery. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[23]  C. Ehrhardt,et al.  Salbutamol is actively absorbed across human bronchial epithelial cell layers. , 2005, Pulmonary pharmacology & therapeutics.

[24]  H. Koepsell,et al.  Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. , 2005, American journal of respiratory cell and molecular biology.

[25]  Lawrence X. Yu,et al.  In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome. , 2004, Current opinion in drug discovery & development.

[26]  H. Junginger,et al.  Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[27]  H. Junginger,et al.  Evidence of P‐glycoprotein mediated apical to basolateral transport of flunisolide in human broncho‐tracheal epithelial cells (Calu‐3) , 2001, British journal of pharmacology.

[28]  R. Schrier.  Diseases of the Kidney and Urinary Tract , 2001 .

[29]  K. Audus,et al.  P-glycoprotein efflux pump expression and activity in Calu-3 cells. , 2001, Journal of pharmaceutical sciences.

[30]  C. Calhau,et al.  Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[31]  J. Nezu,et al.  Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. , 1999, The Journal of pharmacology and experimental therapeutics.

[32]  J. Nezu,et al.  Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. , 1999, The Journal of pharmacology and experimental therapeutics.

[33]  F. Roch-Ramel,et al.  Renal transport of organic ions and uric acid , 1997 .